Abstract
Background: SLNs and NLCs have remarkably wide range of properties which make them useful for several potential applications in drug delivery, clinical medicine, and research, as well as in parenteral, dermal, pulmonary and topical delivery of drugs. The unique size-dependent properties of the solid lipid nanoparticles make them at the forefront of the rapidly developing field of nanotechnology offering development of new therapeutics having reduced toxic side effects and increased treatment efficacy.
Methods: SLNs and NLCs are very attractive drug delivery candidates, primarily due to their relatively stable constituents and probable ease of drug encapsulations. The incorporation of drugs into nanocarriers like SLNs and NLCs for several levels of drug targeting offers good potential in gene transfer, cosmetic and food industry with great promise for reaching the goal of controlled and site-specific drug delivery. Lipid nanoparticle drug delivery technology presents considerable opportunities for improving medical therapeutics, but the technology’s potential remains unrealized.
Results: The review has focused on the various effective delivery routes and strategies for SLNs and NLCs, and their applicability in the encapsulation of therapeutics. Number of research works has been successfully carried out in this area. It would result in a simultaneous improvement in the quality, efficacy, and safety profile of drugs.
Conclusion: However, because of mentioned limitations and difficulties related to them, the total number of products on the market is still limited. Although the concept of PEGylation to increase half-life of nanoparticles revolutionized the nanoparticle-mediated drug-delivery field, significant improvements are warranted in this area.
Keywords: Solid lipid nanoparticles (SLNs), Nanostructured lipid carriers (NLCs), colloidal drug carriers, drug delivery strategies and routes, clinical medicine, gene transfer.
Current Pharmaceutical Design
Title:Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
Volume: 23 Issue: 43
Author(s): Divyesh H. Shastri*
Affiliation:
- Department of Pharmaceutics & Pharmaceutical Technology, K. B. Institute of Pharmaceutical Education & Research, Kadi Sarva Vishwavidyalaya, Gandhinagar, Gujarat,India
Keywords: Solid lipid nanoparticles (SLNs), Nanostructured lipid carriers (NLCs), colloidal drug carriers, drug delivery strategies and routes, clinical medicine, gene transfer.
Abstract: Background: SLNs and NLCs have remarkably wide range of properties which make them useful for several potential applications in drug delivery, clinical medicine, and research, as well as in parenteral, dermal, pulmonary and topical delivery of drugs. The unique size-dependent properties of the solid lipid nanoparticles make them at the forefront of the rapidly developing field of nanotechnology offering development of new therapeutics having reduced toxic side effects and increased treatment efficacy.
Methods: SLNs and NLCs are very attractive drug delivery candidates, primarily due to their relatively stable constituents and probable ease of drug encapsulations. The incorporation of drugs into nanocarriers like SLNs and NLCs for several levels of drug targeting offers good potential in gene transfer, cosmetic and food industry with great promise for reaching the goal of controlled and site-specific drug delivery. Lipid nanoparticle drug delivery technology presents considerable opportunities for improving medical therapeutics, but the technology’s potential remains unrealized.
Results: The review has focused on the various effective delivery routes and strategies for SLNs and NLCs, and their applicability in the encapsulation of therapeutics. Number of research works has been successfully carried out in this area. It would result in a simultaneous improvement in the quality, efficacy, and safety profile of drugs.
Conclusion: However, because of mentioned limitations and difficulties related to them, the total number of products on the market is still limited. Although the concept of PEGylation to increase half-life of nanoparticles revolutionized the nanoparticle-mediated drug-delivery field, significant improvements are warranted in this area.
Export Options
About this article
Cite this article as:
Shastri H. Divyesh *, Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC), Current Pharmaceutical Design 2017; 23 (43) . https://dx.doi.org/10.2174/1381612823666171122111132
DOI https://dx.doi.org/10.2174/1381612823666171122111132 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Combined Virtual Screening Strategies
Current Computer-Aided Drug Design HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
Current Drug Targets At the “Junction” of Spinal Muscular Atrophy Pathogenesis: The Role of Neuromuscular Junction Dysfunction in SMA Disease Progression
Current Molecular Medicine Xanthan Gum and Its Derivatives as a Potential Bio-polymeric Carrier for Drug Delivery System
Current Drug Delivery The Offer of Chemistry to Targeted Therapy in Cancer
Recent Patents on Biotechnology The Potential Health Benefits of Algae and Micro Algae in Medicine: A Review on Spirulina platensis
Current Nutrition & Food Science Costimulation, Coinhibition and Cancer
Current Cancer Drug Targets A New Insight of Herbal Promises Against Ocular Disorders: An Occuloinformatics Approach
Current Topics in Medicinal Chemistry Disordered Proteins and Network Disorder in Network Descriptions of Protein Structure, Dynamics and Function: Hypotheses and a Comprehensive Review
Current Protein & Peptide Science Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design Strategies for Small Molecule Library Design
Current Pharmaceutical Design Programs to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicrobial Acquisition and Coordinating Facility
Infectious Disorders - Drug Targets Nanosuspension: Principles, Perspectives and Practices
Current Drug Delivery Molecularly Imprinted Polymers: Novel Discovery for Drug Delivery
Current Drug Delivery Nucleic Acid Aptamers Against Protein Kinases
Current Medicinal Chemistry Gymnema sylvestre R. Br., an Indian Medicinal Herb: Traditional Uses, Chemical Composition, and Biological Activity
Current Pharmaceutical Biotechnology The Role of Chemokines, Cytokines and Adhesion Molecules in Stem Cell Trafficking and Homing
Current Pharmaceutical Design A Survey on Machine Learning Based Medical Assistive Systems in Current Oncological Sciences
Current Medical Imaging Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology